Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women

Pathology and Oncology Research

Volumn 21, Issue 4, 2015, Pages 935-940

  Michalska, Magdalena M ^a   Samulak, Dariusz ^a,b   Romanowicz, Hanna ^c   Smolarz, Beata ^d  

^a Regional Hospital Kalisz   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c High School of Informatics Regional Hospital in Glowno   (Poland)

^d POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Gene polymorphism; RAD51; Triple negative breast cancer; XRCC2

Indexed keywords

CYTOSINE; RAD51 PROTEIN; THYMINE; DNA BINDING PROTEIN; RAD51 PROTEIN, HUMAN; TUMOR MARKER; XRCC2 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOGENESIS; POLISH CITIZEN; RAD51 GENE; RECOMBINATION REPAIR; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLE NEGATIVE BREAST CANCER; XRCC2 GENE; CANCER GRADING; CANCER STAGING; DOUBLE STRANDED DNA BREAK; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; POLAND; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIPLE NEGATIVE BREAST NEOPLASMS;

ADULT; AGED; BIOMARKERS, TUMOR; DNA BREAKS, DOUBLE-STRANDED; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RAD51 RECOMBINASE; RECOMBINATIONAL DNA REPAIR; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84940447765     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-015-9922-y     Document Type: Article

References (34)

1. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109:1721–1728
2. Chacón RD, Costanzo MV (2010) Triple-negative breast cancer. Breast Cancer Res 12:S3
3. Cleator S, Heller W, Coombes RC (2007) Triple-negative breast cancer: therapeutic options. Lancet Oncol 8:235–244
4. Dawson SJ, Provenzano E, Caldas C (2009) Triple negative breast cancers: clinical and prognostic implications. Eur J Cancer 45:27–40
5. de Ruijter TC, Veeck J, de Hoon JP, van Engeland M, Tjan-Heijnen VC (2011) Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol 137:183–192
6. Jackson SP (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687–696
7. Helleday T (2003) Pathways for mitotic homologous recombination in mammalian cells. Mutat Res 532:103–115
8. Thacker J (2005) The RAD51 gene family, genetic instability and cancer. Cancer Lett 219:125–135
9. Hasselbach L, Haase S, Fischer D, Kolberg HC, Stürzbecher HW (2005) Characterisation of the promoter region of the human DNA-repair gene RAD51. Eur J Gynaecol Oncol 26:589–598
10. Antoniou AC, Sinilnikova OM, Simard J et al (2007) RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81:1186–1200
11. Krivokuca AM, Malisic EJ, Dobricic JD, Brotto KV, Cavic MR, Jankovic RN, Tomasevic ZI, Brankovic-Magic MV (2014) RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women. Fam Cancer.13: 173–80
12. Wang W, Li JL, He XF, Li AP, Cai YL, Xu N, Sun SM, Wu BY (2013) Association between the RAD51 135 G > C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls. PLoS ONE 8:e75153
13. Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfa B, Baszczyński J, Kokołaszwili G, Burzyfiski M, Połać I, Sporny S (2012) The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland. Eur J Gynaecol Oncol 33:145–150
14. Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfal B, Baszczynski J, Polac I, Sporny S (2011) Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women. Tohoku J Exp Med 224:201–208
15. Lee KM, Choi JY, Kang C, Kang CP, Park SK, Cho H, Cho DY, Yoo KY, Noh DY, Ahn SH, Park CG, Wei Q, Kang D (2005) Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 11:4620–4626
16. Shin A, Lee KM, Ahn B, Park CG, Noh SK, Park DY, Ahn SH, Yoo KY, Kang D (2008) Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev 9:501–505
17. Kuschel B, Auranen A, McBride S (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399–40722
18. Thacker J, Zdzienicka MZ (2004) The XRCC genes: expanding roles in DNA double-strand break repair. DNA Repair (Amst) 3:1081–1090
19. Silva SN, Tomar M, Paulo C, Gomes BC, Azevedo AP, Teixeira V, Pina JE, Rueff J, Gaspar JF (2010) Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol 34:85–92
20. Lin WY, Camp NJ, Cannon-Albright LA et al (2011) A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet 48:477–484
21. Sliwinski T, Krupa R, Majsterek I et al (2005) Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast Cancer Res Treat 94:105–109
22. Wang N, Xiu-juan D, Rong-miao Z, Wei G, Xiao-juan Z, Yan L (2009) An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China. Mol Biol Rep 36:357–364
23. Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q (2007) 172G > T variant in the 5′ untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis 28:988–994
24. Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, Courtay-Cahen C, Roberts I, Theillet C, Caldas C, Edwards PA (2000) Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer 83:1309–1317
25. Loveday RL, Greenman J, Simcox DL, Speirs V, Drew PJ, Monson JR, Kerin MJ (2000) Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer 86:494–500
26. Zhao M, Chen P, Dong Y, Zhu X, Zhang X (2014) Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case–control studies. PLoS ONE 9:e87259
27. Smolarz B, Zadrożny M, Duda-Szymańska J, Makowska M, Samulak D, Michalska MM, Mojs E, Bryś M, Forma E, Romanowicz-Makowska H (2013) RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. Pol J Pathol 64:39–43
28. Hosseini M, Houshmand M, Ebrahimi A (2013) RAD51 polymorphisms and breast cancer risk. Mol Biol Rep 40:665–668
29. Romanowicz-Makowska H, Smolarz B, Gajęcka M, Kiwerska K, Rydzanicz M, Kaczmarczyk D, Olszewski J, Szyfter K, Błasiak J, Morawiec-Sztandera A (2012) Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci 8:1065–1075
30. Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La Torre G, Traficante A, Cittadini A (2008) Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case–control study in a Southern Italian population. Anticancer Res 28:2941–2946
31. Lu PH, Li C, Zhou HY, Wang T, Chu CQ, Shen W, Tao GQ (2011) Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk. Breast Cancer Res Treat 125:299–300
32. Sliwinski T, Walczak A, Przybylowska K et al (2010) Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a polish population. Exp Mol Pathol 89:358–366
33. Li F, Li C, Jiang Z, Ma N, Gao X (2011) XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis. Urology 77:511–515
34. Smolarz B, Samulak D, Michalska M, Góralczyk B, Szyłło K, Lewy J, Sporny S, Kokołaszwili G, Burzyński M, Romanowicz-Makowska H (2011) 135G > C and 172G > T polymorphism in the 5′ untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women. Pol J Pathol 62:157–162